[1] SUNG H,FERLARY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2]左婷婷,郑荣寿,曾红梅,等.中国胃癌流行病学现状[J].中国肿瘤临床,2017,44(01):52-58.
ZYO TT,ZHENG RS,ZENG HM,et al.Status of the epidemiology of gastric cancer in China[J].Chinese Journal of Clinical Oncology,2017,44(01):52-58.
[3]DIAKOS CI,CHARLES KA,MCMILLAN DC,et al.Cancer-related inflammation and treatment effectiveness[J].Lancet Oncol,2014,15(11):493-503.
[4]NASZAI M,KURJAN A,MAUGHAN TS.The prognostic utility of pre-treatment neutrophil-to-lymphocyte-ratio (NLR) in colorectal cancer:a systematic review and meta-analysis[J].Cancer Med,2021,10(17):5983-5997.
[5]WANG J,LI H,XU R,et al.The MLR,NLR,PLR and D-dimer are associated with clinical outcome in lung cancer patients treated with surgery[J].BMC Pulm Med,2022,22(1):104.
[6] ROMANO L,GIUNIALI A,TOMARELLI C,et al.Impact of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios on long-term survival in patients with operable pancreatic ductal adenocarcinoma[J].Med Princ Pract,2022,31(6):586-594.
[7]OCHI H,KUROSAKI M,JOKO K,et al.Usefulness of neutrophil-to-lymphocyte ratio in predicting progression and survival outcomes after atezolizumab-bevacizumab treatment for hepatocellular carcinoma[J].Hepatol Res,2023,53(1):61-71.
[8]CAGLAR R.The relationship of different preoperative inflammatory markers with the prognosis of gastric carcinoma[J].Asian J Surg,2023,46(1):360-365.
[9]胡蝶,马玲.术前NLR与卵巢癌预后的相关性研究[J].现代肿瘤医学,2018,26(17):2790-2793.
HU D,MA L.Research on the correlation between preoperative NLR and prognosis of ovarian cancer[J].Modern Oncology,2018,26(17):2790-2793.
[10]LI LL,PAN LS.Prognostic value of neutrophil-to-lymphocyte ratio in gastric cancer patients treated with immune checkpoint inhibitors:a meta-analysis[J].Kaohsiung J Med Sci,2023,39(8):842-852.
[11]KWAK JS,KIM SG,LEE SE,et al.The role of postoperative neutrophil-to-lymphocyte ratio as a predictor of postoperative major complications following total gastrectomy for gastric cancer[J].Ann Surg Treat Res,2022,103(3):153-159.
[12]LIN JX,WANG ZK,HUANG YQ,et al.Dynamic changes in pre-and postoperative levels of inflammatory markers and their effects on the prognosis of patients with gastric cancer[J].J Gastrointest Surg,2021,25(2):387-396.
[13]Japanese Gastric Cancer Association.Japanese gastric cancer treatment guidelines 2014 (ver.4)[J].Gastric Cancer,2017,20:1-19.
[14]XU Z,CHEN X,YUAN J,WANG C,et al.Correlations of preoperative systematic immuno-inflammatory index and prognostic nutrition index with a prognosis of patients after radical gastric cancer surgery[J].Surgery,2022,172(1):150-159.
[15]HAN Y,WU J,JI R,et al.Preoperative sarcopenia combined with prognostic nutritional index predicts long-term prognosis of radical gastrectomy with advanced gastric cancer:a comprehensive analysis of two-center study[J].BMC Cancer,2023,23(1):751.
[16]ZHAO W,LIU M,ZHANG M,et al.Effects of inflammation on the immune microenvironment in gastric cancer[J].Front Oncol,2021,11:690298.
[17]COUSSENS LM,WERB Z.Inflammation and cancer[J].Nature,2002,420(6917):860-867.
[18]KIM SG,EOM BW,YOON H,et al.Prognostic value of preoperative systemic inflammatory parameters in advanced gastric cancer[J].J Clin Med,2022,11(18):5318.
[19]XIANG Y,ZHANG N,LEI H,et al.Neutrophil-to-lymphocyte ratio is a negative prognostic biomarker for luminal A breast cancer[J].Gland Surg,2023,12(3):415-425.
[20]DENG Z,LU L,LI B,et al.The roles of inflammasomes in cancer[J].Front Immunol,2023,14:1195572.
[21]WANG H,WANG Z,HOU Z,et al.The neutrophil-to-lymphocyte ratio (NLR) predicts the prognosis of unresectable intermediate and advanced hepatocellular carcinoma treated with apatinib[J].Cancer Manag Res,2021,13:6989-6998.
[22]ZHANG Q,LAI Q,WANG S,et al.Clinical value of postoperative neutrophil-to-lymphocyte ratio change as a detection marker of bladder cancer recurrence[J].Cancer Manag Res,2021,13:849-860.
[23]KIM JH,LEE JH,LEE HS,et al.Elevated neutrophil-to-lymphocyte ratio in perioperative periods is suggestive of poor prognosis in patients with colorectal cancer[J].J Inflamm Res,2021,14:4457-4466.
[24]KIM EY,SONG KY.The preoperative and the postoperative neutrophil-to-lymphocyte ratios both predict prognosis in gastric cancer patients[J].World J Surg Oncol,2020,18(1):293.
[25]MIYATANI K,SAITO H,KONO Y,et al.Combined analysis of the pre-and postoperative neutrophil-lymphocyte ratio predicts the outcomes of patients with gastric cancer[J].Surg Today,2018,48(3):300-307.
[26]CHAN JCY,DIAKOS CI,CHAN DLH,et al.A longitudinal investigation of inflammatory markers in colorectal cancer patients perioperatively demonstrates benefit in serial remeasurement[J].Ann Surg,2018,267(6):1119-1125.